SCHEDULE 13G/A: Brown Advisory and Affiliates Disclose 17.4% Stake in Guardian Pharmacy Services

Brown Advisory Inc. and its affiliated entities have reported a combined beneficial ownership of 17.4% of Guardian Pharmacy Services, Inc.'s Class A Common Stock as of December 31, 2024.

Summary

• The filing is an Amendment No. 1 to Schedule 13G, reporting beneficial ownership of Class A Common Stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (CUSIP: 40145W101).
• The reporting persons are BROWN ADVISORY INC, BROWN INVESTMENT ADVISORY & TRUST CO, Brown Advisory LLC, and Signature Financial Management, Inc., all primarily based in Maryland, except for Signature Financial Management, Inc. which is based in Virginia.
• As of December 31, 2024, the aggregate amount beneficially owned by BROWN ADVISORY INC is 1,598,597 shares, representing 17.4% of the class.
• BROWN INVESTMENT ADVISORY & TRUST CO beneficially owns 23,114 shares, representing 0.3% of the class.
• Brown Advisory LLC beneficially owns 1,575,483 shares, representing 17.1% of the class.
• Signature Financial Management, Inc. beneficially owns 1,717 shares, representing 0% of the class (due to rounding, as it's less than 0.1%).
• BROWN ADVISORY INC holds sole voting power over 1,591,537 shares and shared dispositive power over 1,598,597 shares.
• Brown Advisory LLC holds sole voting power over 1,568,423 shares and shared dispositive power over 1,575,483 shares.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
• Brown Advisory Incorporated (BAI) is filing as a parent holding company on behalf of its subsidiaries: Brown Investment Advisory & Trust Company (BIATC), Brown Advisory LLC (BALLC), and Signature Financial Management, Inc. (Signature).

Sentiment

Score: 6

Explanation: The filing is a routine disclosure of beneficial ownership by a passive investor, indicating a significant stake in the company. While not directly impacting operations, it signals confidence from a major investment firm, which is generally a positive signal for the market.

Positives

• A significant stake (17.4%) held by a reputable investment firm like Brown Advisory indicates a strong vote of confidence in Guardian Pharmacy Services, Inc.
• The filing explicitly states that the shares are held in the ordinary course of business and not for control purposes, suggesting a passive, long-term investment perspective.

Negatives

• No specific negatives are indicated in this beneficial ownership filing, as it primarily serves as a disclosure of ownership.

Risks

• The reporting persons are passive investors and do not intend to change or influence the control of the issuer, meaning they will not actively push for strategic or operational changes within Guardian Pharmacy Services, Inc.

Future Outlook

This Schedule 13G filing does not contain any forward-looking statements or guidance regarding the future outlook of Guardian Pharmacy Services, Inc. or the reporting persons' investment strategy beyond the certification of passive intent.

Management Comments

• "To the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."

Industry Context

This filing highlights a significant passive investment by a major asset management firm in the pharmacy services sector. Such an investment suggests that institutional investors see long-term value or stability in Guardian Pharmacy Services, Inc. or the broader healthcare/pharmacy industry.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by a reputable investment firm may be viewed positively, potentially boosting investor confidence.
• Management: Awareness of a large, passive institutional shareholder may influence strategic considerations, though the filing explicitly states no intent to influence control.

Next Steps

• Future amendments to this Schedule 13G will be filed if there are material changes in the beneficial ownership percentage (e.g., an increase or decrease of more than 1% of the class).

Key Dates

Keywords

Guardian Pharmacy Services, Brown Advisory, Schedule 13G, Beneficial Ownership, Class A Common Stock, Investment, SEC Filing, Institutional Investor, Passive Investment